Michael S. Torbenson, M.D.

  1. Pathologist

Publications

  1. Lunn B, Yasir S, Lam-Himlin D, Menias CO, Torbenson MS, Venkatesh SK. Anastomosing hemangioma of the liver: a case series. Abdom Radiol (NY). 2019 Aug; 44 (8):2781-2787
    View PubMed
  2. Arnold CA, Graham RP, Jain D, Kakar S, Lam-Himlin DM, Naini BV, Wu TT, Yeh MM, Torbenson MS. Knowledge gaps in the appendix: a multi-institutional study from seven academic centers. Mod Pathol. 2019 Jul; 32 (7):988-996 Epub 2019 Feb 14
    View PubMed
  3. Venkatesh SK, Hoodeshenas S, Venkatesh SH, Dispenzieri A, Gertz MA, Torbenson MS, Ehman RL. Magnetic Resonance Elastography of Liver in Light Chain Amyloidosis. J Clin Med. 2019 May 23; 8 (5)
    View PubMed
  4. Torbenson MS, Arnold CA, Graham RP, Jain D, Kakar S, Lam-Himlin DM, Naini BV, Wu TT, Yeh M. Identification of key challenges in liver pathology: data from a multicenter study of extramural consults. Hum Pathol. 2019 May; 87:75-82 Epub 2019 Mar 08
    View PubMed
  5. Yasir S, Torbenson MS. Angiosarcoma of the Liver: Clinicopathologic Features and Morphologic Patterns. Am J Surg Pathol. 2019 May; 43 (5):581-590
    View PubMed
  6. Wilson GC, Lluis N, Nalesnik MA, Nassar A, Serrano T, Ramos E, Torbenson M, Asbun HJ, Geller DA. Hepatic Angiosarcoma: A Multi-institutional, International Experience with 44 Cases. Ann Surg Oncol. 2019 Feb; 26 (2):576-582 Epub 2018 Nov 19
    View PubMed
  7. Navin PJ, Hilscher MB, Welle CL, Mounajjed T, Torbenson MS, Kamath PS, Venkatesh SK. The Utility of MR Elastography to Differentiate Nodular Regenerative Hyperplasia from Cirrhosis. Hepatology. 2019 Jan; 69 (1):452-454 Epub 2018 Dec 25
    View PubMed
  8. Torbenson MS. Hamartomas and malformations of the liver. Semin Diagn Pathol. 2019 Jan; 36 (1):39-47 Epub 2018 Nov 17
    View PubMed
  9. Graham RP, Lackner C, Terracciano L, Gonzalez-Cantu Y, Maleszewski JJ, Greipp PT, Simon SM, Torbenson MS. Fibrolamellar carcinoma in the Carney complex: PRKAR1A loss instead of the classic DNAJB1-PRKACA fusion. Hepatology. 2018 Oct; 68 (4):1441-1447 Epub 2018 May 11
    View PubMed
  10. AlFarkh W, Torbenson MS, Mounajjed T. Benign hepatic lesions arising in accessory hepatic lobes AJSP-Reviews And Reports. 2018 Sep-oct; 23 (5):241-5
  11. Lee HE, Wu TT, Chandan VS, Torbenson MS, Mounajjed T. Colonic Adenomatous Polyps Involving Submucosal Lymphoglandular Complexes: A Diagnostic Pitfall. Am J Surg Pathol. 2018 Aug; 42 (8):1083-1089
    View PubMed
  12. Ehman EC, Torbenson MS, Wells ML, Welch BT, Thompson SM, Garg I, Venkatesh SK. Hepatic tumors of vascular origin: imaging appearances. Abdom Radiol (NY). 2018 Aug; 43 (8):1978-1990
    View PubMed
  13. Torbenson M. Hepatic Adenomas: Classification, Controversies, and Consensus. Surg Pathol Clin. 2018 Jun; 11 (2):351-366 Epub 2018 Mar 26
    View PubMed
  14. Chandan VS, Shah SS, Mounajjed T, Torbenson MS, Wu TT. Copper deposition in focal nodular hyperplasia and inflammatory hepatocellular adenoma. J Clin Pathol. 2018 Jun; 71 (6):504-507 Epub 2017 Nov 10
    View PubMed
  15. Jones D, Manns MP, Terracciano L, Torbenson M, Vierling JM. Unmet needs and new models for future trials in autoimmune hepatitis. Lancet Gastroenterol Hepatol. 2018 May; 3 (5):363-370 Epub 2018 Apr 06
    View PubMed
  16. Nath MC, Torbenson MS, Erickson LA. Desmoid Tumor. Mayo Clin Proc. 2018 Apr; 93 (4):549-550
    View PubMed
  17. Hammond WJ, Lalazar G, Saltsman JA, Farber BA, Danzer E, Sherpa TC, Banda CD, Andolina JR, Karimi S, Brennan CW, Torbenson MS, La Quaglia MP, Simon SM. Intracranial metastasis in fibrolamellar hepatocellular carcinoma. Pediatr Blood Cancer. 2018 Apr; 65 (4) Epub 2017 Dec 29
    View PubMed
  18. Nath MC, Torbenson MS, Erickson LA. Perihilar Cholangiocarcinoma. Mayo Clin Proc. 2018 Mar; 93 (3):397-398
    View PubMed
  19. Graham RP, Naini BV, Shah SS, Arnold CA, Kannangai R, Torbenson MS, Lam-Himlin DM. Treponema pallidum Immunohistochemistry is positive in human intestinal Spirochetosis. Diagn Pathol. 2018 Jan 22; 13 (1):7
    View PubMed
  20. Graham RP, Yeh MM, Lam-Himlin D, Roberts LR, Terracciano L, Cruise MW, Greipp PT, Zreik RT, Jain D, Zaid N, Salaria SN, Jin L, Wang X, Rustin JG, Kerr SE, Sukov WR, Solomon DA, Kakar S, Waterhouse E, Gill RM, Ferrell L, Alves VA, Nart D, Yilmaz F, Roessler S, Longerich T, Schirmacher P, Torbenson MS. Molecular testing for the clinical diagnosis of fibrolamellar carcinoma. Mod Pathol. 2018 Jan; 31 (1):141-149 Epub 2017 Sept 01
    View PubMed
  21. Clark I, Shah SS, Moreira R, Graham RP, Wu TT, Torbenson MS, Chandan V. A subset of well-differentiated hepatocellular carcinomas are Arginase-1 negative. Hum Pathol. 2017 Nov; 69:90-95 Epub 2017 Sept 29
    View PubMed
  22. Garg I, Graham RP, VanBuren WM, Goenka AH, Torbenson MS, Venkatesh SK. Hepatic segmental atrophy and nodular elastosis: imaging features. Abdom Radiol (NY). 2017 Oct; 42 (10):2447-2453
    View PubMed
  23. Czeczok TW, Van Arnam JS, Wood LD, Torbenson MS, Mounajjed T. The Almost-Normal Liver Biopsy: Presentation, Clinical Associations, and Outcome. Am J Surg Pathol. 2017 Sep; 41 (9):1247-1253
    View PubMed
  24. Horowitz JM, Venkatesh SK, Ehman RL, Jhaveri K, Kamath P, Ohliger MA, Samir AE, Silva AC, Taouli B, Torbenson MS, Wells ML, Yeh B, Miller FH. Evaluation of hepatic fibrosis: a review from the society of abdominal radiology disease focus panel. Abdom Radiol (NY). 2017 Aug; 42 (8):2037-2053
    View PubMed
  25. Farshidfar F, Zheng S, Gingras MC, Newton Y, Shih J, Robertson AG, Hinoue T, Hoadley KA, Gibb EA, Roszik J, Covington KR, Wu CC, Shinbrot E, Stransky N, Hegde A, Yang JD, Reznik E, Sadeghi S, Pedamallu CS, Ojesina AI, Hess JM, Auman JT, Rhie SK, Bowlby R, Borad MJ, Zhu AX, Stuart JM, Sander C, Akbani R, Cherniack AD, Deshpande V, Mounajjed T, Foo WC, Torbenson MS, Kleiner DE, Laird PW, Wheeler DA, McRee AJ, Bathe OF, Andersen JB, Bardeesy N, Roberts LR, Kwong LN, Cancer Genome Atlas Network. Integrative Genomic Analysis of Cholangiocarcinoma Identifies Distinct IDH-Mutant Molecular Profiles. Cell Rep. 2017 Jun 27; 19 (13):2878-2880
    View PubMed
  26. Shah SS, Wu TT, Torbenson MS, Chandan VS. Aberrant CDX2 expression in hepatocellular carcinomas: an important diagnostic pitfall. Hum Pathol. 2017 Jun; 64:13-18 Epub 2017 Jan 13
    View PubMed
  27. Mukewar S, Sharma A, Lackore KA, Enders FT, Torbenson MS, Kamath PS, Roberts LR, Kudva YC. Clinical, Biochemical, and Histopathology Features of Patients With Glycogenic Hepatopathy. Clin Gastroenterol Hepatol. 2017 Jun; 15 (6):927-933 Epub 2016 Dec 30
    View PubMed
  28. Graham RP, Craig JR, Jin L, Oliveira AM, Bergquist JR, Truty MJ, Mounajjed T, Greipp PT, Torbenson MS. Environmental exposures as a risk factor for fibrolamellar carcinoma. Mod Pathol. 2017 Jun; 30 (6):892-896 Epub 2017 Mar 03
    View PubMed
  29. Daniel HD, Torbenson M. Transgenic hepatitis B: a new model of HBV infection. Sci Rep. 2017 Jun 1; 7 (1):2610 Epub 2017 June 01
    View PubMed
  30. Torbenson MS. Morphologic Subtypes of Hepatocellular Carcinoma. Gastroenterol Clin North Am. 2017 Jun; 46 (2):365-391
    View PubMed
  31. Mahadev S, Murray JA, Wu TT, Chandan VS, Torbenson MS, Kelly CP, Maki M, Green PH, Adelman D, Lebwohl B. Factors associated with villus atrophy in symptomatic coeliac disease patients on a gluten-free diet. Aliment Pharmacol Ther. 2017 Apr; 45 (8):1084-1093 Epub 2017 Feb 20
    View PubMed
  32. Dinh TA, Vitucci EC, Wauthier E, Graham RP, Pitman WA, Oikawa T, Chen M, Silva GO, Greene KG, Torbenson MS, Reid LM, Sethupathy P. Comprehensive analysis of The Cancer Genome Atlas reveals a unique gene and non-coding RNA signature of fibrolamellar carcinoma. Sci Rep. 2017 Mar 17; 7:44653
    View PubMed
  33. Farshidfar F, Zheng S, Gingras MC, Newton Y, Shih J, Robertson AG, Hinoue T, Hoadley KA, Gibb EA, Roszik J, Covington KR, Wu CC, Shinbrot E, Stransky N, Hegde A, Yang JD, Reznik E, Sadeghi S, Pedamallu CS, Ojesina AI, Hess JM, Auman JT, Rhie SK, Bowlby R, Borad MJ, Zhu AX, Stuart JM, Sander C, Akbani R, Cherniack AD, Deshpande V, Mounajjed T, Foo WC, Torbenson MS, Kleiner DE, Laird PW, Wheeler DA, McRee AJ, Bathe OF, Andersen JB, Bardeesy N, Roberts LR, Kwong LN, Cancer Genome Atlas Network. Integrative Genomic Analysis of Cholangiocarcinoma Identifies Distinct IDH-Mutant Molecular Profiles. Cell Rep. 2017 Mar 14; 18 (11):2780-2794
    View PubMed
  34. Graham RP, Torbenson MS. Fibrolamellar carcinoma: A histologically unique tumor with unique molecular findings. Semin Diagn Pathol. 2017 Mar; 34: (2)146-152.
    View PubMed
  35. Clark I, Torbenson MS. Immunohistochemistry and Special Stains in Medical Liver Pathology. Adv Anat Pathol. 2017 Mar; 24: (2)99-109.
    View PubMed
  36. Fritchie KJ, Jin L, Wang X, Graham RP, Torbenson MS, Lewis JE, Rivera M, Garcia JJ, Schembri-Wismayer DJ, Westendorf JJ, Chou MM, Dong J, Oliveira AM. Fusion gene profile of biphenotypic sinonasal sarcoma: an analysis of 44 cases. Histopathology. 2016 Dec; 69 (6):930-936 Epub 2016 Sept 23
    View PubMed
  37. Young JT, Kurup AN, Graham RP, Torbenson MS, Venkatesh SK. Myxoid hepatocellular neoplasms: imaging appearance of a unique mucinous tumor variant. Abdom Radiol (NY). 2016 Nov; 41 (11):2115-2122
    View PubMed
  38. Blackburn PR, Hickey RD, Nace RA, Giama NH, Kraft DL, Bordner AJ, Chaiteerakij R, McCormick JB, Radulovic M, Graham RP, Torbenson MS, Tortorelli S, Scott CR, Lindor NM, Milliner DS, Oglesbee D, Al-Qabandi W, Grompe M, Gavrilov DK, El-Youssef M, Clark KJ, Atwal PS, Roberts LR, Klee EW, Ekker SC. Silent Tyrosinemia Type I Without Elevated Tyrosine or Succinylacetone Associated with Liver Cirrhosis and Hepatocellular Carcinoma. Hum Mutat. 2016 Oct; 37 (10):1097-105 Epub 2016 Aug 08
    View PubMed
  39. Wang Y, Ding X, Wang S, Moser CD, Shaleh HM, Mohamed EA, Chaiteerakij R, Allotey LK, Chen G, Miyabe K, McNulty MS, Ndzengue A, Barr Fritcher EG, Knudson RA, Greipp PT, Clark KJ, Torbenson MS, Kipp BR, Zhou J, Barrett MT, Gustafson MP, Alberts SR, Borad MJ, Roberts LR. Antitumor effect of FGFR inhibitors on a novel cholangiocarcinoma patient derived xenograft mouse model endogenously expressing an FGFR2-CCDC6 fusion protein. Cancer Lett. 2016 Sep 28; 380 (1):163-73 Epub 2016 May 20
    View PubMed
  40. Chandan VS, Shah SS, Torbenson MS, Wu TT. Arginase-1 is frequently positive in hepatoid adenocarcinomas. Hum Pathol. 2016 Sep; 55:11-6 Epub 2016 Apr 30
    View PubMed
  41. Liu L, Shah SS, Naini BV, French S, Wu TT, Torbenson MS, Chandan VS. Immunostains Used to Subtype Hepatic Adenomas Do Not Distinguish Hepatic Adenomas From Hepatocellular Carcinomas. Am J Surg Pathol. 2016 Aug; 40 (8):1062-9
    View PubMed
  42. Mahamoud HD, Muse SM, Roberts LR, Fischer PR, Torbenson MS, Fader T. Khat chewing and cirrhosis in Somaliland: Case series. Afr J Prim Health Care Fam Med. 2016 Jul 28; 8 (1):e1-4 Epub 2016 July 28
    View PubMed
  43. Graham RP, Terracciano LM, Meves A, Vanderboom PM, Dasari S, Yeh MM, Torbenson MS, Cruise MW. Hepatic adenomas with synchronous or metachronous fibrolamellar carcinomas: both are characterized by LFABP loss. Mod Pathol. 2016 Jun; 29 (6):607-15 Epub 2016 Mar 25
    View PubMed
  44. Schafer MJ, White TA, Evans G, Tonne JM, Verzosa GC, Stout MB, Mazula DL, Palmer AK, Baker DJ, Jensen MD, Torbenson MS, Miller JD, Ikeda Y, Tchkonia T, van Deursen JM, Kirkland JL, LeBrasseur NK. Exercise Prevents Diet-Induced Cellular Senescence in Adipose Tissue. Diabetes. 2016 Jun; 65 (6):1606-15 Epub 2016 Mar 16
    View PubMed
  45. Dhanasekaran R, Venkatesh SK, Torbenson MS, Roberts LR. Erratum to "Clinical implications of basic research in hepatocellular carcinoma" [J Hepatol 2016;64:736-745]. J Hepatol. 2016 Jun; 64 (6):1462 Epub 2016 Mar 22
    View PubMed
  46. Gupta S, Naini BV, Munoz R, Graham RP, Kipp BR, Torbenson MS, Mounajjed T. Hepatocellular Neoplasms Arising in Association With Androgen Use. Am J Surg Pathol. 2016 Apr; 40: (4)454-61.
    View PubMed
  47. Graham RP, Garcia JJ, Greipp PT, Barr Fritcher EG, Kipp BR, Torbenson MS. FGFR1 and FGFR2 in fibrolamellar carcinoma. Histopathology. 2016 Apr; 68 (5):686-92 Epub 2015 Oct 05
    View PubMed
  48. Lehrke HD, Torbenson MS, Erickson LA. Man With Fever and Severe Diarrhea. Mayo Clin Proc. 2016 Apr; 91: (4)e55-6.
    View PubMed
  49. Dhanasekaran R, Venkatesh SK, Torbenson MS, Roberts LR. Clinical implications of basic research in hepatocellular carcinoma. J Hepatol. 2016 Mar; 64 (3):736-45 Epub 2015 Oct 09
    View PubMed
  50. Yeh MM, Liu Y, Torbenson M. Steatohepatitic variant of hepatocellular carcinoma in the absence of metabolic syndrome or background steatosis: a clinical, pathological, and genetic study. Hum Pathol. 2015 Nov; 46 (11):1769-75 Epub 2015 Aug 04
    View PubMed
  51. Leyva F, Fuchs EJ, Bakshi R, Carballo-Dieguez A, Ventuneac A, Yue C, Caffo B, Du Y, Torbenson M, Li L, Mullin G, Lee L, Rohan L, Anton PA, Hendrix CW. Simultaneous Evaluation of Safety, Acceptability, Pericoital Kinetics, and Ex Vivo Pharmacodynamics Comparing Four Rectal Microbicide Vehicle Candidates. AIDS Res Hum Retroviruses. 2015 Nov; 31 (11):1089-97 Epub 2015 July 08
    View PubMed
  52. Mesarwi OA, Shin MK, Drager LF, Bevans-Fonti S, Jun JC, Putcha N, Torbenson MS, Pedrosa RP, Lorenzi-Filho G, Steele KE, Schweitzer MA, Magnuson TH, Lidor AO, Schwartz AR, Polotsky VY. Lysyl Oxidase as a Serum Biomarker of Liver Fibrosis in Patients with Severe Obesity and Obstructive Sleep Apnea. Sleep. 2015 Oct 1; 38 (10):1583-91 Epub 2015 Oct 01
    View PubMed
  53. Mounajjed T, Yasir S, Aleff PA, Torbenson MS. Pigmented hepatocellular adenomas have a high risk of atypia and malignancy. Mod Pathol. 2015 Sep; 28 (9):1265-74 Epub 2015 July 24
    View PubMed
  54. Nguyen T, Phillips D, Jain D, Torbenson M, Wu TT, Yeh MM, Kakar S. Comparison of 5 Immunohistochemical Markers of Hepatocellular Differentiation for the Diagnosis of Hepatocellular Carcinoma. Arch Pathol Lab Med. 2015 Aug; 139(8):1028-34.
    View PubMed
  55. Hourigan SK, Torbenson M, Tibesar E, Scheimann AO. The full spectrum of hepatic steatosis in children. Clin Pediatr (Phila). 2015 Jun; 54: (7)635-42.
    View PubMed
  56. Graham RP, Jin L, Knutson DL, Kloft-Nelson SM, Greipp PT, Waldburger N, Roessler S, Longerich T, Roberts LR, Oliveira AM, Halling KC, Schirmacher P, Torbenson MS. DNAJB1-PRKACA is specific for fibrolamellar carcinoma. Mod Pathol. 2015 Jun; 28 (6):822-9 Epub 2015 Feb 20
    View PubMed
  57. Chandan VS, Shah SS, Lam-Himlin DM, Petris GD, Mereuta OM, Dogan A, Torbenson MS, Wu TT. Globular hepatic amyloid is highly sensitive and specific for LECT2 amyloidosis. Am J Surg Pathol. 2015 Apr; 39(4):558-64.
    View PubMed
  58. Hourigan SK, Abrams S, Yates K, Pfeifer K, Torbenson M, Murray K, Roth CL, Kowdley K, Scheimann AO, NASH CRN. Relation between vitamin D status and nonalcoholic fatty liver disease in children. J Pediatr Gastroenterol Nutr. 2015 Mar; 60 (3):396-404
    View PubMed
  59. Graham RP, Salaria SN, Aishima S, Mounajjed T, Yeh MM, Torbenson MS. Primary Hepatic Tumors with Myxoid Change: Morphologically Unique Hepatic Adenomas and Hepatocellular Carcinomas Am J Surg Path.;39(3)318-24.
    View PubMed
  60. Knabel MK, Ramachandran K, Karhadkar S, Hwang HW, Creamer TJ, Chivukula RR, Sheikh F, Clark KR, Torbenson M, Montgomery RA, Cameron AM, Mendell JT, Warren DS. Systemic Delivery of scAAV8-Encoded MiR-29a Ameliorates Hepatic Fibrosis in Carbon Tetrachloride-Treated Mice. PLoS One. 2015; 10 (4):e0124411 Epub 2015 Apr 29
    View PubMed
  61. Joseph NM, Ferrell LD, Jain D, Torbenson MS, Wu TT, Yeh MM, Kakar S. Diagnostic utility and limitations of glutamine synthetase and serum amyloid-associated protein immunohistochemistry in the distinction of focal nodular hyperplasia and inflammatory hepatocellular adenoma. Mod Pathol. 2014 Jan; 27(1):62-72. Epub 2013 Jun 28.
    View PubMed
  62. Brunt EM, Gouw ASH, Hubscher SG, Tiniakos DG, Bedossa P, Burt AD, Callea F, Clouston AD, Dienes HP, Goodman ZD, Roberts EA, Roskams T, Terracciano L, Torbenson MS, Wanless IR. Pathology of the liver sinusoids. Histopathology. 2014; 64(7):907-20.
    View PubMed
  63. Graham RP, Torbenson MS. Fibrolamellar carcinoma: Diagnosis and diagnostic pitfalls. Pathology Case Reviews. 2014; 19(6):309-15.
  64. Wood LD, Heaphy CM, Daniel HD, Naini BV, Lassman CR, Arroyo MR, Kamel IR, Cosgrove DP, Boitnott JK, Meeker AK, Torbenson MS. Chromophobe hepatocellular carcinoma with abrupt anaplasia: a proposal for a new subtype of hepatocellular carcinoma with unique morphological and molecular features. Mod Pathol. 2013 Dec; 26(12):1586-93. Epub 2013 May 03.
    View PubMed
  65. Mathai AM, Alexander J, Kuo FY, Torbenson M, Swanson PE, Yeh MM. Type II ground-glass hepatocytes as a marker of hepatocellular carcinoma in chronic hepatitis B. Hum Pathol. 2013 Aug; 44(8):1665-71. Epub 2013 Apr 08.
    View PubMed
  66. Gonzalez-Roibon N, Katz B, Chaux A, Sharma R, Munari E, Faraj SF, Illei PB, Torbenson M, Netto GJ. Immunohistochemical expression of SALL4 in hepatocellular carcinoma, a potential pitfall in the differential diagnosis of yolk sac tumors. Hum Pathol. 2013 Jul; 44(7):1293-9. Epub 2013 Jan 21.
    View PubMed
  67. Krings G, Ramachandran R, Jain D, Wu TT, Yeh MM, Torbenson M, Kakar S. Immunohistochemical pitfalls and the importance of glypican 3 and arginase in the diagnosis of scirrhous hepatocellular carcinoma. Mod Pathol. 2013 Jun; 26(6):782-91. Epub 2013 Jan 25.
    View PubMed
  68. Alexander J, Torbenson M, Wu TT, Yeh MM. Non-alcoholic fatty liver disease contributes to hepatocarcinogenesis in non-cirrhotic liver: a clinical and pathological study. J Gastroenterol Hepatol. 2013 May; 28(5):848-54.
    View PubMed
  69. Killela PJ, Reitman ZJ, Jiao Y, Bettegowda C, Agrawal N, Diaz LA Jr, Friedman AH, Friedman H, Gallia GL, Giovanella BC, Grollman AP, He TC, He Y, Hruban RH, Jallo GI, Mandahl N, Meeker AK, Mertens F, Netto GJ, Rasheed BA, Riggins GJ, Rosenquist TA, Schiffman M, Shih IeM, Theodorescu D, Torbenson MS, Velculescu VE, Wang TL, Wentzensen N, Wood LD, Zhang M, McLendon RE, Bigner DD, Kinzler KW, Vogelstein B, Papadopoulos N, Yan H. TERT promoter mutations occur frequently in gliomas and a subset of tumors derived from cells with low rates of self-renewal. Proc Natl Acad Sci U S A. 2013 Apr 9; 110(15):6021-6. Epub 2013 Mar 25.
    View PubMed
  70. Zheng G, Martignoni G, Antonescu C, Montgomery E, Eberhart C, Netto G, Taube J, Westra W, Epstein JI, Lotan T, Maitra A, Gabrielson E, Torbenson M, Iacobuzio-Donahue C, Demarzo A, Shih IeM, Illei P, Wu TC, Argani P. A broad survey of cathepsin K immunoreactivity in human neoplasms. Am J Clin Pathol. 2013 Feb; 139(2):151-9.
    View PubMed
  71. El-Maouche D, Mehta SH, Sutcliffe CG, Higgins Y, Torbenson MS, Moore RD, Thomas DL, Sulkowski MS, Brown TT. Vitamin D deficiency and its relation to bone mineral density and liver fibrosis in HIV-HCV coinfection. Antivir Ther. 2013; 18(2):237-42. Epub 2012 Aug 07.
    View PubMed
  72. Petersen SM, Gendelman M, Murphy KM, Torbenson M, Jones RJ, Stetten G, Bird C, Blakemore KJ. In utero hematopoietic stem cell transplantation in canines: exploring the gestational age window of opportunity to maximize engraftment. Fetal Diagn Ther. 2013; 33(2):116-21. Epub 2013 Jan 19.
    View PubMed
  73. Ang CS, Kelley RK, Choti MA, Cosgrove DP, Chou JF, Klimstra D, Torbenson MS, Ferrell L, Pawlik TM, Fong Y, O'Reilly EM, Ma J, McGuire J, Vallarapu GP, Griffin A, Stipa F, Capanu M, Dematteo RP, Venook AP, Abou-Alfa GK. Clinicopathologic characteristics and survival outcomes of patients with fibrolamellar carcinoma: data from the fibrolamellar carcinoma consortium. Gastrointest Cancer Res. 2013 Jan; 6(1):3-9.
    View PubMed
  74. Balabaud C, Al-Rabih WR, Chen PJ, Evason K, Ferrell L, Hernandez-Prera JC, Huang SF, Longerich T, Park YN, Quaglia A, Schirmacher P, Sempoux C, Thung SN, Torbenson M, Wee A, Yeh MM, Yeh SH, Le Bail B, Zucman-Rossi J, Bioulac-Sage P. Focal Nodular Hyperplasia and Hepatocellular Adenoma around the World Viewed through the Scope of the Immunopathological Classification. Int J Hepatol. 2013; 2013:268625. Epub 2013 Apr 14.
    View PubMed
  75. Wild AT, Gandhi N, Chettiar ST, Aziz K, Gajula RP, Williams RD, Kumar R, Taparra K, Zeng J, Cades JA, Velarde E, Menon S, Geschwind JF, Cosgrove D, Pawlik TM, Maitra A, Wong J, Hales RK, Torbenson MS, Herman JM, Tran PT. Concurrent versus sequential sorafenib therapy in combination with radiation for hepatocellular carcinoma. PLoS One. 2013; 8(6):e65726. Epub 2013 Jun 06.
    View PubMed
  76. Wang MH, Okazaki T, Kugathasan S, Cho JH, Isaacs KL, Lewis JD, Smoot DT, Valentine JF, Kader HA, Ford JG, Harris ML, Oliva-Hemker M, Cuffari C, Torbenson MS, Duerr RH, Silverberg MS, Rioux JD, Taylor KD, Nguyen GC, Wu Y, Datta LW, Hooker S, Dassopoulos T, Kittles RA, Kao LW, Brant SR. Contribution of higher risk genes and European admixture to Crohn's disease in African Americans. Inflamm Bowel Dis. 2012 Dec; 18(12):2277-87. Epub 2012 Mar 12.
    View PubMed
  77. Liu TC, Nguyen TT, Torbenson MS. Concurrent increase in mitosis and apoptosis: a histological pattern of hepatic arterial flow abnormalities in post-transplant liver biopsies. Mod Pathol. 2012 Dec; 25(12):1594-8. Epub 2012 Jul 06.
    View PubMed
  78. Munshaw S, Hwang HS, Torbenson M, Quinn J, Hansen KD, Astemborski J, Mehta SH, Ray SC, Thomas DL, Balagopal A. Laser captured hepatocytes show association of butyrylcholinesterase gene loss and fibrosis progression in hepatitis C-infected drug users. Hepatology. 2012 Aug; 56(2):544-54. Epub 2012 Jul 6
    View PubMed
  79. Limketkai BN, Mehta SH, Sutcliffe CG, Higgins YM, Torbenson MS, Brinkley SC, Moore RD, Thomas DL, Sulkowski MS. Relationship of liver disease stage and antiviral therapy with liver-related events and death in adults coinfected with HIV/HCV. JAMA. 2012 Jul 25; 308(4):370-8.
    View PubMed
  80. Yamanaka S, Olaru AV, An F, Luvsanjav D, Jin Z, Agarwal R, Tomuleasa C, Popescu I, Alexandrescu S, Dima S, Chivu-Economescu M, Montgomery EA, Torbenson M, Meltzer SJ, Selaru FM. MicroRNA-21 inhibits Serpini1, a gene with novel tumour suppressive effects in gastric cancer. Dig Liver Dis. 2012 Jul; 44(7):589-96. Epub 2012 Mar 28.
    View PubMed
  81. O'Donnell KA, Keng VW, York B, Reineke EL, Seo D, Fan D, Silverstein KA, Schrum CT, Xie WR, Mularoni L, Wheelan SJ, Torbenson MS, O'Malley BW, Largaespada DA, Boeke JD. A Sleeping Beauty mutagenesis screen reveals a tumor suppressor role for Ncoa2/Src-2 in liver cancer. Proc Natl Acad Sci U S A. 2012 May 22; 109(21):E1377-86. Epub 2012 May 3
    View PubMed
  82. Singhi AD, Jain D, Kakar S, Wu TT, Yeh MM, Torbenson M. Reticulin loss in benign fatty liver: an important diagnostic pitfall when considering a diagnosis of hepatocellular carcinoma. Am J Surg Pathol. 2012 May; 36(5):710-5.
    View PubMed
  83. Roy A, Wang C, Li C, Lu L, Torbenson M, Hagedorn CH, Schwarz KB. Phenotypic and genotypic differences between a child with vertically acquired severe hepatitis C liver disease and his mother. J Pediatr Gastroenterol Nutr. 2012 Apr; 54(4):567-9.
    View PubMed
  84. Guerrerio AL, Colvin RM, Schwartz AK, Molleston JP, Murray KF, Diehl A, Mohan P, Schwimmer JB, Lavine JE, Torbenson MS, Scheimann AO. Choline intake in a large cohort of patients with nonalcoholic fatty liver disease. Am J Clin Nutr. 2012 Apr; 95(4):892-900. Epub 2012 Feb 15.
    View PubMed
  85. Ganapathy-Kanniappan S, Kunjithapatham R, Torbenson MS, Rao PP, Carson KA, Buijs M, Vali M, Geschwind JF. Human hepatocellular carcinoma in a mouse model: assessment of tumor response to percutaneous ablation by using glyceraldehyde-3-phosphate dehydrogenase antagonists. Radiology. 2012 Mar; 262(3):834-45.
    View PubMed
  86. Louissaint NA, Nimmagadda S, Fuchs EJ, Bakshi RP, Cao YJ, Lee LA, Goldsmith J, Caffo BS, Du Y, King KE, Menendez FA, Torbenson MS, Hendrix CW. Distribution of cell-free and cell-associated HIV surrogates in the colon after simulated receptive anal intercourse in men who have sex with men. J Acquir Immune Defic Syndr. 2012 Jan 1; 59(1):10-7.
    View PubMed
  87. Thompson AJ, Patel K, Chuang WL, Lawitz EJ, Rodriguez-Torres M, Rustgi VK, Flisiak R, Pianko S, Diago M, Arora S, Foster GR, Torbenson M, Benhamou Y, Nelson DR, Sulkowski MS, Zeuzem S, Pulkstenis E, Subramanian GM, McHutchison JG, ACHIEVE-1 and ACHIEVE-2/3 Study Teams. Viral clearance is associated with improved insulin resistance in genotype 1 chronic hepatitis C but not genotype 2/3. Gut. 2012 Jan; 61(1):128-34. Epub 2011 Aug 26.
    View PubMed
  88. Torbenson M. Fibrolamellar carcinoma: 2012 update. Scientifica. 2012.
  89. Olaru AV, Ghiaur G, Yamanaka S, Luvsanjav D, An F, Popescu I, Alexandrescu S, Allen S, Pawlik TM, Torbenson M, Georgiades C, Roberts LR, Gores GJ, Ferguson-Smith A, Almeida MI, Calin GA, Mezey E, Selaru FM. MicroRNA down-regulated in human cholangiocarcinoma control cell cycle through multiple targets involved in the G1/S checkpoint. Hepatology. 2011 Dec; 54(6):2089-98.
    View PubMed
  90. Patel K, Friedrich-Rust M, Lurie Y, Grigorescu M, Stanciu C, Lee CM, Schiff ER, Haussinger D, Manns MP, Gerken G, Colle I, Torbenson M, Pulkstenis E, Subramanian GM, McHutchison JG, Zeuzem S. FibroSURE and FibroScan in relation to treatment response in chronic hepatitis C virus. World J Gastroenterol. 2011 Nov 7; 17(41):4581-9.
    View PubMed
  91. Bonekamp S, Torbenson MS, Kamel IR. Diffusion-weighted magnetic resonance imaging for the staging of liver fibrosis. J Clin Gastroenterol. 2011 Nov-Dec; 45(10):885-92.
    View PubMed
  92. Zhao H, Wang J, Han Y, Huang Z, Ying J, Bi X, Zhao J, Fang Y, Zhou H, Zhou J, Li Z, Zhang Y, Yang X, Yan T, Wang L, Torbenson MS, Cai J. ARID2: a new tumor suppressor gene in hepatocellular carcinoma. Oncotarget. 2011 Nov; 2(11):886-91.
    View PubMed
  93. El-Maouche D, Mehta SH, Sutcliffe C, Higgins Y, Torbenson MS, Moore RD, Thomas DL, Sulkowski MS, Brown TT. Controlled HIV viral replication, not liver disease severity associated with low bone mineral density in HIV/HCV co-infection. J Hepatol. 2011 Oct; 55(4):770-6. Epub 2011 Feb 19.
    View PubMed
  94. Heaphy CM, Subhawong AP, Hong SM, Goggins MG, Montgomery EA, Gabrielson E, Netto GJ, Epstein JI, Lotan TL, Westra WH, Shih IeM, Iacobuzio-Donahue CA, Maitra A, Li QK, Eberhart CG, Taube JM, Rakheja D, Kurman RJ, Wu TC, Roden RB, Argani P, De Marzo AM, Terracciano L, Torbenson M, Meeker AK. Prevalence of the alternative lengthening of telomeres telomere maintenance mechanism in human cancer subtypes. Am J Pathol. 2011 Oct; 179(4):1608-15. Epub 2011 Sep 1
    View PubMed
  95. Li M, Zhao H, Zhang X, Wood LD, Anders RA, Choti MA, Pawlik TM, Daniel HD, Kannangai R, Offerhaus GJ, Velculescu VE, Wang L, Zhou S, Vogelstein B, Hruban RH, Papadopoulos N, Cai J, Torbenson MS, Kinzler KW. Inactivating mutations of the chromatin remodeling gene ARID2 in hepatocellular carcinoma. Nat Genet. 2011 Sep; 43(9):828-9. Epub 2011 Aug 07.
    View PubMed
  96. Torbenson M. Iron in the liver: a review for surgical pathologists. Adv Anat Pathol. 2011 Jul; 18(4):306-17.
    View PubMed
  97. Jiang X, Leong D, Ren Y, Li Z, Torbenson MS, Mao HQ. String-like micellar nanoparticles formed by complexation of PEG-b-PPA and plasmid DNA and their transfection efficiency. Pharm Res. 2011 Jun; 28(6):1317-27. Epub 2011 Apr 16.
    View PubMed
  98. Holdhoff M, Schmidt K, Diehl F, Aggrawal N, Angenendt P, Romans K, Edelstein DL, Torbenson M, Kinzler KW, Vogelstein B, Choti MA, Diaz LA. Detection of tumor DNA at the margins of colorectal cancer liver metastasis. Clin Cancer Res. 2011 Jun 1; 17(11):3551-7. Epub 2011 Apr 29.
    View PubMed
  99. Singhi AD, Adsay NV, Swierczynski SL, Torbenson M, Anders RA, Hruban RH, Argani P. Hyperplastic Luschka ducts: a mimic of adenocarcinoma in the gallbladder fossa. Am J Surg Pathol. 2011 Jun; 35(6):883-90.
    View PubMed
  100. Ross HM, Daniel HD, Vivekanandan P, Kannangai R, Yeh MM, Wu TT, Makhlouf HR, Torbenson M. Fibrolamellar carcinomas are positive for CD68. Mod Pathol. 2011 Mar; 24(3):390-5. Epub 2010 Nov 26
    View PubMed
  101. Vivekanandan P, Torbenson M, Ramakrishna B. Hepatitis B virus-associated hepatocellular carcinoma from India: role of viral genotype and mutations in CTNNB1 (beta-catenin) and TP53 genes. J Gastrointest Cancer. 2011 Mar; 42(1):20-5.
    View PubMed
  102. Woreta TA, Sutcliffe CG, Mehta SH, Brown TT, Higgins Y, Thomas DL, Torbenson MS, Moore RD, Sulkowski MS. Incidence and risk factors for steatosis progression in adults coinfected with HIV and hepatitis C virus. Gastroenterology. 2011 Mar; 140(3):809-17. Epub 2010 Dec 04.
    View PubMed
  103. Singhi AD, Maklouf HR, Mehrotra AK, Goodman ZD, Drebber U, Dienes HP, Torbenson M. Segmental atrophy of the liver: a distinctive pseudotumor of the liver with variable histologic appearances. Am J Surg Pathol. 2011 Mar; 35(3):364-71.
    View PubMed
  104. Drebber U, Torbenson M, Wedemeyer I, Dienes HP. [Current aspects of liver allograft pathology]. Pathologe. 2011 Mar; 32(2):113-23.
    View PubMed
  105. Kemp CD, Arnold CA, Torbenson MS, Stein EM. An unusual polyp: a pedunculated leiomyoma of the sigmoid colon. Endoscopy. 2011; 43 Suppl 2 UCTN:E306-7. Epub 2011 Sep 13.
    View PubMed
  106. Torbenson M, Hart J, Westerhoff M, Azzam RK, Elgendi A, Mziray-Andrew HC, Kim GE, Scheimann A. Neonatal giant cell hepatitis: histological and etiological findings. Am J Surg Pathol. 2010 Oct; 34(10):1498-503.
    View PubMed
  107. van Vledder MG, Torbenson MS, Pawlik TM, Boctor EM, Hamper UM, Olino K, Choti MA. The effect of steatosis on echogenicity of colorectal liver metastases on intraoperative ultrasonography. Arch Surg. 2010 Jul; 145(7):661-7.
    View PubMed
  108. Vivekanandan P, Daniel H, Yeh MM, Torbenson M. Mitochondrial mutations in hepatocellular carcinomas and fibrolamellar carcinomas. Mod Pathol. 2010 Jun; 23(6):790-8. Epub 2010 Mar 12.
    View PubMed
  109. Vivekanandan P, Daniel HD, Kannangai R, Martinez-Murillo F, Torbenson M. Hepatitis B virus replication induces methylation of both host and viral DNA. J Virol. 2010 May; 84(9):4321-9. Epub 2010 Feb 10.
    View PubMed
  110. Lam M, Torbenson M, Yeh MM, Vivekanandan P, Ferrell L. HFE mutations in alpha-1-antitrypsin deficiency: an examination of cirrhotic explants. Mod Pathol. 2010 May; 23(5):637-43. Epub 2010 Mar 05.
    View PubMed
  111. Brown TT, Mehta SH, Sutcliffe C, Higgins Y, Torbenson MS, Moore RD, Thomas DL, Sulkowski MS. Hepatic steatosis associated with increased central body fat by dual-energy X-ray absorptiometry and uncontrolled HIV in HIV/hepatitis C co-infected persons. AIDS. 2010 Mar 27; 24(6):811-7.
    View PubMed
  112. Yeh MM, Daniel HD, Torbenson M. Hepatitis C-associated hepatocellular carcinomas in non-cirrhotic livers. Mod Pathol. 2010 Feb; 23(2):276-83. Epub 2009 Nov 20.
    View PubMed
  113. Lee J, Wang J, Torbenson M, Lu Y, Liu QZ, Li S. Loss of SDHB and NF1 genes in a malignant phyllodes tumor of the breast as detected by oligo-array comparative genomic hybridization. Cancer Genet Cytogenet. 2010 Jan 15; 196(2):179-83.
    View PubMed
  114. Ding M, Potter JJ, Liu X, Torbenson MS, Mezey E. Selenium supplementation decreases hepatic fibrosis in mice after chronic carbon tetrachloride administration. Biol Trace Elem Res. 2010 Jan; 133(1):83-97. Epub 2009 Jun 02.
    View PubMed
  115. Torbenson M. Glycogenic Hepatology. Pathology Case Reviews. 2010; 15(3):72-76.
  116. Balagopal A, Ray SC, De Oca RM, Sutcliffe CG, Vivekanandan P, Higgins Y, Mehta SH, Moore RD, Sulkowski MS, Thomas DL, Torbenson MS. Kupffer cells are depleted with HIV immunodeficiency and partially recovered with antiretroviral immune reconstitution. AIDS. 2009 Nov 27; 23(18):2397-404.
    View PubMed
  117. Reyes DK, Vossen JA, Kamel IR, Azad NS, Wahlin TA, Torbenson MS, Choti MA, Geschwind JF. Single-center phase II trial of transarterial chemoembolization with drug-eluting beads for patients with unresectable hepatocellular carcinoma: initial experience in the United States. Cancer J. 2009 Nov-Dec; 15(6):526-32.
    View PubMed
  118. Kota J, Chivukula RR, O'Donnell KA, Wentzel EA, Montgomery CL, Hwang HW, Chang TC, Vivekanandan P, Torbenson M, Clark KR, Mendell JR, Mendell JT. Therapeutic microRNA delivery suppresses tumorigenesis in a murine liver cancer model. Cell. 2009 Jun 12; 137(6):1005-17.
    View PubMed
  119. Selaru FM, Olaru AV, Kan T, David S, Cheng Y, Mori Y, Yang J, Paun B, Jin Z, Agarwal R, Hamilton JP, Abraham J, Georgiades C, Alvarez H, Vivekanandan P, Yu W, Maitra A, Torbenson M, Thuluvath PJ, Gores GJ, LaRusso NF, Hruban R, Meltzer SJ. MicroRNA-21 is overexpressed in human cholangiocarcinoma and regulates programmed cell death 4 and tissue inhibitor of metalloproteinase 3. Hepatology. 2009 May; 49(5):1595-601.
    View PubMed
  120. Vivekanandan P, Thomas D, Torbenson M. Methylation regulates hepatitis B viral protein expression. J Infect Dis. 2009 May 1; 199(9):1286-91.
    View PubMed
  121. Fenton H, Torbenson M, Vivekanandan P, Yeh MM, Hart J, Ferrell L. Marked iron in liver explants in the absence of major hereditary hemochromatosis gene defects: a risk factor for cardiac failure. Transplantation. 2009 Apr 27; 87(8):1256-60.
    View PubMed
  122. Kirk GD, Astemborski J, Mehta SH, Spoler C, Fisher C, Allen D, Higgins Y, Moore RD, Afdhal N, Torbenson M, Sulkowski M, Thomas DL. Assessment of liver fibrosis by transient elastography in persons with hepatitis C virus infection or HIV-hepatitis C virus coinfection. Clin Infect Dis. 2009 Apr 1; 48(7):963-72.
    View PubMed
  123. Daniels JA, Torbenson M, Vivekanandan P, Anders RA, Boitnott JK. Hepatitis in common variable immunodeficiency. Hum Pathol. 2009 Apr; 40(4):484-8. Epub 2008 Dec 11.
    View PubMed
  124. Aram G, Potter JJ, Liu X, Wang L, Torbenson MS, Mezey E. Deficiency of nicotinamide adenine dinucleotide phosphate, reduced form oxidase enhances hepatocellular injury but attenuates fibrosis after chronic carbon tetrachloride administration. Hepatology. 2009 Mar; 49(3):911-9.
    View PubMed
  125. Vivekanandan P, Micchelli ST, Torbenson M. Anterior gradient-2 is overexpressed by fibrolamellar carcinomas. Hum Pathol. 2009 Mar; 40(3):293-9. Epub 2008 Oct 29.
    View PubMed
  126. Patel K, Benhamou Y, Yoshida EM, Kaita KD, Zeuzem S, Torbenson M, Pulkstenis E, Subramanian GM, McHutchison JG. An independent and prospective comparison of two commercial fibrosis marker panels (HCV FibroSURE and FIBROSpect II) during albinterferon alfa-2b combination therapy for chronic hepatitis C. J Viral Hepat. 2009 Mar; 16(3):178-86. Epub 2008 Oct 24.
    View PubMed
  127. Savransky V, Reinke C, Jun J, Bevans-Fonti S, Nanayakkara A, Li J, Myers AC, Torbenson MS, Polotsky VY. Chronic intermittent hypoxia and acetaminophen induce synergistic liver injury in mice. Exp Physiol. 2009 Feb; 94(2):228-39. Epub 2008 Nov 21.
    View PubMed
  128. Daniels JA, Torbenson M, Anders RA, Boitnott JK. Immunostaining of plasma cells in primary biliary cirrhosis. Am J Clin Pathol. 2009 Feb; 131(2):243-9.
    View PubMed
  129. Polotsky VY, Patil SP, Savransky V, Laffan A, Fonti S, Frame LA, Steele KE, Schweizter MA, Clark JM, Torbenson MS, Schwartz AR. Obstructive sleep apnea, insulin resistance, and steatohepatitis in severe obesity. Am J Respir Crit Care Med. 2009 Feb 1; 179(3):228-34. Epub 2008 Oct 31
    View PubMed
  130. Ready T, Johnson E, Torbenson M, Aufderheide A. Overmodeled skulls from North America. Overmodeled skulls. 2009.
  131. Chaerkady R, Harsha HC, Nalli A, Gucek M, Vivekanandan P, Akhtar J, Cole RN, Simmers J, Schulick RD, Singh S, Torbenson M, Pandey A, Thuluvath PJ. A quantitative proteomic approach for identification of potential biomarkers in hepatocellular carcinoma. J Proteome Res. 2008 Oct; 7(10):4289-98. Epub 2008 Aug 21.
    View PubMed
  132. Lee KH, Liapi E, Vossen JA, Buijs M, Ventura VP, Georgiades C, Hong K, Kamel I, Torbenson MS, Geschwind JF. Distribution of iron oxide-containing Embosphere particles after transcatheter arterial embolization in an animal model of liver cancer: evaluation with MR imaging and implication for therapy. J Vasc Interv Radiol. 2008 Oct; 19(10):1490-6. Epub 2008 Aug 27
    View PubMed
  133. Micchelli ST, Thomas D, Boitnott JK, Torbenson M. Hepatic giant cells in hepatitis C virus (HCV) mono-infection and HCV/HIV co-infection. J Clin Pathol. 2008 Sep; 61(9):1058-61. Epub 2008 Aug 04.
    View PubMed
  134. Chaerkady R, Thuluvath PJ, Kim MS, Nalli A, Vivekanandan P, Simmers J, Torbenson M, Pandey A. O Labeling for a Quantitative Proteomic Analysis of Glycoproteins in Hepatocellular Carcinoma. Clin Proteomics. 2008 Jul 18; 4(3-4):137-55.
    View PubMed
  135. Vivekanandan P, Torbenson M. Epigenetic instability is rare in fibrolamellar carcinomas but common in viral-associated hepatocellular carcinomas. Mod Pathol. 2008 Jun; 21(6):670-5. Epub 2008 Feb 08.
    View PubMed
  136. Aram G, Potter JJ, Liu X, Torbenson MS, Mezey E. Lack of inducible nitric oxide synthase leads to increased hepatic apoptosis and decreased fibrosis in mice after chronic carbon tetrachloride administration. Hepatology. 2008 Jun; 47(6):2051-8.
    View PubMed
  137. Vivekanandan P, Kannangai R, Ray SC, Thomas DL, Torbenson M. Comprehensive genetic and epigenetic analysis of occult hepatitis B from liver tissue samples. Clin Infect Dis. 2008 Apr 15; 46(8):1227-36.
    View PubMed
  138. Micchelli ST, Vivekanandan P, Boitnott JK, Pawlik TM, Choti MA, Torbenson M. Malignant transformation of hepatic adenomas. Mod Pathol. 2008 Apr; 21(4):491-7. Epub 2008 Feb 01.
    View PubMed
  139. Vivekanandan P, Thomas D, Torbenson M. Hepatitis B viral DNA is methylated in liver tissues. J Viral Hepat. 2008 Feb; 15(2):103-7.
    View PubMed
  140. Vivekanandan P, Torbenson M. Low frequency of Helicobacter DNA in benign and malignant liver tissues from Baltimore, United States. Hum Pathol. 2008 Feb; 39(2):213-6. Epub 2007 Oct 18.
    View PubMed
  141. Ma X, Torbenson M, Hamad AR, Soloski MJ, Li Z. High-fat diet modulates non-CD1d-restricted natural killer T cells and regulatory T cells in mouse colon and exacerbates experimental colitis. Clin Exp Immunol. 2008 Jan; 151(1):130-8. Epub 2007 Nov 07.
    View PubMed
  142. Verma S, Torbenson M, Thuluvath PJ. The impact of ethnicity on the natural history of autoimmune hepatitis. Hepatology. 2007 Dec; 46(6):1828-35.
    View PubMed
  143. Johnson K, Kotiesh A, Boitnott JK, Torbenson M. Histology of symptomatic acute hepatitis C infection in immunocompetent adults. Am J Surg Pathol. 2007 Nov; 31(11):1754-8.
    View PubMed
  144. Sulkowski MS, Mehta SH, Torbenson MS, Higgins Y, Brinkley SC, de Oca RM, Moore RD, Afdhal NH, Thomas DL. Rapid fibrosis progression among HIV/hepatitis C virus-co-infected adults. AIDS. 2007 Oct 18; 21(16):2209-16.
    View PubMed
  145. Jiang X, Dai H, Ke CY, Mo X, Torbenson MS, Li Z, Mao HQ. PEG-b-PPA/DNA micelles improve transgene expression in rat liver through intrabiliary infusion. J Control Release. 2007 Oct 8; 122(3):297-304. Epub 2007 Jun 22.
    View PubMed
  146. Savransky V, Bevans S, Nanayakkara A, Li J, Smith PL, Torbenson MS, Polotsky VY. Chronic intermittent hypoxia causes hepatitis in a mouse model of diet-induced fatty liver. Am J Physiol Gastrointest Liver Physiol. 2007 Oct; 293(4):G871-7. Epub 2007 Aug 09.
    View PubMed
  147. Torbenson M, Yeh MM, Abraham SC. Bile duct dysplasia in the setting of chronic hepatitis C and alcohol cirrhosis. Am J Surg Pathol. 2007 Sep; 31(9):1410-3.
    View PubMed
  148. Pawlik TM, Olino K, Gleisner AL, Torbenson M, Schulick R, Choti MA. Preoperative chemotherapy for colorectal liver metastases: impact on hepatic histology and postoperative outcome. J Gastrointest Surg. 2007 Jul; 11(7):860-8.
    View PubMed
  149. Wang XH, Netski DM, Astemborski J, Mehta SH, Torbenson MS, Thomas DL, Ray SC. Progression of fibrosis during chronic hepatitis C is associated with rapid virus evolution. J Virol. 2007 Jun; 81(12):6513-22. Epub 2007 Feb 28.
    View PubMed
  150. Kannangai R, Vivekanandan P, Netski D, Mehta S, Kirk GD, Thomas DL, Torbenson M. Liver enzyme flares and occult hepatitis B in persons with chronic hepatitis C infection. J Clin Virol. 2007 Jun; 39(2):101-5. Epub 2007 Apr 23.
    View PubMed
  151. Torbenson M. Review of the clinicopathologic features of fibrolamellar carcinoma. Adv Anat Pathol. 2007 May; 14(3):217-23.
    View PubMed
  152. Krok KL, Torbenson MS, Schulick RD, Thuluvath PJ. Lymphadenopathy, elevated liver function tests and weight loss in a 68-year-old man. J Dig Dis. 2007 May; 8(2):103-6.
    View PubMed
  153. Kannangai R, Vivekanandan P, Martinez-Murillo F, Choti M, Torbenson M. Fibrolamellar carcinomas show overexpression of genes in the RAS, MAPK, PIK3, and xenobiotic degradation pathways. Hum Pathol. 2007 Apr; 38(4):639-44.
    View PubMed
  154. Savransky V, Nanayakkara A, Vivero A, Li J, Bevans S, Smith PL, Torbenson MS, Polotsky VY. Chronic intermittent hypoxia predisposes to liver injury. Hepatology. 2007 Apr; 45(4):1007-13.
    View PubMed
  155. Fuchs EJ, Lee LA, Torbenson MS, Parsons TL, Bakshi RP, Guidos AM, Wahl RL, Hendrix CW. Hyperosmolar sexual lubricant causes epithelial damage in the distal colon: potential implication for HIV transmission. J Infect Dis. 2007 Mar 1; 195(5):703-10. Epub 2007 Jan 23.
    View PubMed
  156. Kobeiter H, Georgiades CS, Leakakos T, Torbenson M, Hong K, Geschwind JF. Targeted transarterial therapy of Vx-2 rabbit liver tumor with Yttrium-90 labeled ferromagnetic particles using an external magnetic field. Anticancer Res. 2007 Mar-Apr; 27(2):755-60.
    View PubMed
  157. Dorfman JD, Schulick R, Choti MA, Geschwind JF, Kamel I, Torbenson M, Thuluvath PJ. Differences in characteristics of patients with and without known risk factors for hepatocellular carcinoma in the United States. World J Gastroenterol. 2007 Feb 7; 13(5):781-4.
    View PubMed
  158. Petersen SM, Gendelman M, Murphy KM, Torbenson M, Jones RJ, Althaus JE, Stetten G, Bird C, Blakemore KJ. Use of T-cell antibodies for donor dosaging in a canine model of in utero hematopoietic stem cell transplantation. Fetal Diagn Ther. 2007; 22(3):175-9. Epub 2007 Jan 16.
    View PubMed
  159. Vali M, Liapi E, Kowalski J, Hong K, Khwaja A, Torbenson MS, Georgiades C, Geschwind JF. Intraarterial therapy with a new potent inhibitor of tumor metabolism (3-bromopyruvate): identification of therapeutic dose and method of injection in an animal model of liver cancer. J Vasc Interv Radiol. 2007 Jan; 18(1 Pt 1):95-101.
    View PubMed
  160. Torbenson M, Erlen J. A quantitative profile of the patent medicine industry in Baltimore from 1863 to 1930. Pharm Hist. 2007; 49(1):15-27.
    View PubMed
  161. Torbenson M, Barker N. Selling the cure: images of health and disease in early American patent medicine advertisement. Journal of Biocommunications. 2007; 33(3):47-53.
  162. Mehta SH, Lucas GM, Mirel LB, Torbenson M, Higgins Y, Moore RD, Thomas DL, Sulkowski MS. Limited effectiveness of antiviral treatment for hepatitis C in an urban HIV clinic. AIDS. 2006 Nov 28; 20(18):2361-9.
    View PubMed
  163. Jevremovic D, Torbenson M, Murray JA, Burgart LJ, Abraham SC. Atrophic autoimmune pangastritis: A distinctive form of antral and fundic gastritis associated with systemic autoimmune disease. Am J Surg Pathol. 2006 Nov; 30(11):1412-9.
    View PubMed
  164. Kannangai R, Sahin F, Torbenson MS. EGFR is phosphorylated at Ty845 in hepatocellular carcinoma. Mod Pathol. 2006 Nov; 19(11):1456-61. Epub 2006 Aug 25.
    View PubMed
  165. Maheshwari A, Torbenson MS, Thuluvath PJ. Sirolimus monotherapy versus sirolimus in combination with steroids and/or MMF for immunosuppression after liver transplantation. Dig Dis Sci. 2006 Oct; 51(10):1677-84.
    View PubMed
  166. Perumal V, Wang J, Thuluvath P, Choti M, Torbenson M. Hepatitis C and hepatitis B nucleic acids are present in intrahepatic cholangiocarcinomas from the United States. Hum Pathol. 2006 Sep; 37(9):1211-6. Epub 2006 Jul 18.
    View PubMed
  167. Wisell J, Boitnott J, Haas M, Anders RA, Hart J, Lewis JT, Abraham SC, Torbenson M. Glycogen pseudoground glass change in hepatocytes. Am J Surg Pathol. 2006 Sep; 30(9):1085-90.
    View PubMed
  168. Xu X, Kobayashi S, Qiao W, Li C, Xiao C, Radaeva S, Stiles B, Wang RH, Ohara N, Yoshino T, LeRoith D, Torbenson MS, Gores GJ, Wu H, Gao B, Deng CX. Induction of intrahepatic cholangiocellular carcinoma by liver-specific disruption of Smad4 and Pten in mice. J Clin Invest. 2006 Jul; 116(7):1843-52. Epub 2006 Jun 08.
    View PubMed
  169. Brastianos PK, Swanson JW, Torbenson M, Sperati J, Karakousis PC. Tuberculosis-associated haemophagocytic syndrome. Lancet Infect Dis. 2006 Jul; 6(7):447-54.
    View PubMed
  170. Hong K, Khwaja A, Liapi E, Torbenson MS, Georgiades CS, Geschwind JF. New intra-arterial drug delivery system for the treatment of liver cancer: preclinical assessment in a rabbit model of liver cancer. Clin Cancer Res. 2006 Apr 15; 12(8):2563-7.
    View PubMed
  171. Sicklick JK, Li YX, Jayaraman A, Kannangai R, Qi Y, Vivekanandan P, Ludlow JW, Owzar K, Chen W, Torbenson MS, Diehl AM. Dysregulation of the Hedgehog pathway in human hepatocarcinogenesis. Carcinogenesis. 2006 Apr; 27(4):748-57. Epub 2005 Dec 08.
    View PubMed
  172. Wilson LE, Torbenson M, Astemborski J, Faruki H, Spoler C, Rai R, Mehta S, Kirk GD, Nelson K, Afdhal N, Thomas DL. Progression of liver fibrosis among injection drug users with chronic hepatitis C. Hepatology. 2006 Apr; 43(4):788-95.
    View PubMed
  173. Torbenson M, Chen YY, Brunt E, Cummings OW, Gottfried M, Jakate S, Liu YC, Yeh MM, Ferrell L. Glycogenic hepatopathy: an underrecognized hepatic complication of diabetes mellitus. Am J Surg Pathol. 2006 Apr; 30(4):508-13.
    View PubMed
  174. Solga SF, Alkhuraishe A, Cope K, Tabesh A, Clark JM, Torbenson M, Schwartz P, Magnuson T, Diehl AM, Risby TH. Breath biomarkers and non-alcoholic fatty liver disease: preliminary observations. Biomarkers. 2006 Mar-Apr; 11(2):174-83.
    View PubMed
  175. Dai H, Jiang X, Tan GC, Chen Y, Torbenson M, Leong KW, Mao HQ. Chitosan-DNA nanoparticles delivered by intrabiliary infusion enhance liver-targeted gene delivery. Int J Nanomedicine. 2006; 1(4):507-22.
    View PubMed
  176. Torbenson M. Emerging causes of morbidity and mortality in organ transplant patients. Current Opinion in Solid Organ Transplantation. 2006; 11(3):304-10.
  177. Hong K, Kobeiter H, Georgiades CS, Torbenson MS, Geschwind JF. Effects of the type of embolization particles on carboplatin concentration in liver tumors after transcatheter arterial chemoembolization in a rabbit model of liver cancer. J Vasc Interv Radiol. 2005 Dec; 16(12):1711-7.
    View PubMed
  178. Sicklick JK, Li YX, Choi SS, Qi Y, Chen W, Bustamante M, Huang J, Zdanowicz M, Camp T, Torbenson MS, Rojkind M, Diehl AM. Role for hedgehog signaling in hepatic stellate cell activation and viability. Lab Invest. 2005 Nov; 85(11):1368-80.
    View PubMed
  179. Klein WM, Molmenti EP, Colombani PM, Grover DS, Schwarz KB, Boitnott J, Torbenson MS. Primary liver carcinoma arising in people younger than 30 years. Am J Clin Pathol. 2005 Oct; 124(4):512-8.
    View PubMed
  180. Kleiner DE, Brunt EM, Van Natta M, Behling C, Contos MJ, Cummings OW, Ferrell LD, Liu YC, Torbenson MS, Unalp-Arida A, Yeh M, McCullough AJ, Sanyal AJ, Nonalcoholic Steatohepatitis Clinical Research Network. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology. 2005 Jun; 41(6):1313-21.
    View PubMed
  181. Torbenson M, Grover D, Boitnott J, Klein A, Molmenti E. De novo hepatocellular carcinoma in a liver allograft associated with recurrent hepatitis B. Transplant Proc. 2005 Jun; 37(5):2205-6.
    View PubMed
  182. Kannangai R, Diehl AM, Sicklick J, Rojkind M, Thomas D, Torbenson M. Hepatic angiomyolipoma and hepatic stellate cells share a similar gene expression profile. Hum Pathol. 2005 Apr; 36(4):341-7.
    View PubMed
  183. Sulkowski MS, Mehta SH, Torbenson M, Afdhal NH, Mirel L, Moore RD, Thomas DL. Hepatic steatosis and antiretroviral drug use among adults coinfected with HIV and hepatitis C virus. AIDS. 2005 Mar 24; 19(6):585-92.
    View PubMed
  184. Solga SF, Clark JM, Alkhuraishi AR, Torbenson M, Tabesh A, Schweitzer M, Diehl AM, Magnuson TH. Race and comorbid factors predict nonalcoholic fatty liver disease histopathology in severely obese patients. Surg Obes Relat Dis. 2005 Jan-Feb; 1(1):6-11.
    View PubMed
  185. Kannangai R, Wang J, Liu QZ, Sahin F, Torbenson M. Survivin overexpression in hepatocellular carcinoma is associated with p53 dysregulation. Int J Gastrointest Cancer. 2005; 35(1):53-60.
    View PubMed
  186. Mehta SH, Thomas DL, Torbenson M, Brinkley S, Mirel L, Chaisson RE, Moore RD, Sulkowski MS. The effect of antiretroviral therapy on liver disease among adults with HIV and hepatitis C coinfection. Hepatology. 2005 Jan; 41(1):123-31.
    View PubMed
  187. Locke JE, Choti MA, Torbenson MS, Horton KM, Molmenti EP. Inflammatory pseudotumor of the liver. J Hepatobiliary Pancreat Surg. 2005; 12(4):314-6.
    View PubMed
  188. Sahin F, Kannangai R, Adegbola O, Wang J, Su G, Torbenson M. mTOR and P70 S6 kinase expression in primary liver neoplasms. Clin Cancer Res. 2004 Dec 15; 10(24):8421-5.
    View PubMed
  189. Ko YH, Smith BL, Wang Y, Pomper MG, Rini DA, Torbenson MS, Hullihen J, Pedersen PL. Advanced cancers: eradication in all cases using 3-bromopyruvate therapy to deplete ATP. Biochem Biophys Res Commun. 2004 Nov 5; 324(1):269-75.
    View PubMed
  190. Solga S, Alkhuraishe AR, Clark JM, Torbenson M, Greenwald A, Diehl AM, Magnuson T. Dietary composition and nonalcoholic fatty liver disease. Dig Dis Sci. 2004 Oct; 49(10):1578-83.
    View PubMed
  191. Torbenson M, Kannangai R, Abraham S, Sahin F, Choti M, Wang JZ. Concurrent evaluation of p53, beta-catenin, and alpha-fetoprotein expression in human hepatocellular carcinoma. Am J Clin Pathol. 2004 Sep; 122(3):377-82.
    View PubMed
  192. Kulesza P, Torbenson M, Sheth S, Erozan YS, Ali SZ. Cytopathologic grading of hepatocellular carcinoma on fine-needle aspiration. Cancer. 2004 Aug 25; 102(4):247-58.
    View PubMed
  193. Kannangai R, Molmenti E, Arrazola L, Klein A, Choti M, Thomas DL, Torbenson M. Occult hepatitis B viral DNA in liver carcinomas from a region with a low prevalence of chronic hepatitis B infection. J Viral Hepat. 2004 Jul; 11(4):297-301.
    View PubMed
  194. Kannangai R, Sahin F, Adegbola O, Ashfaq R, Su GH, Torbenson M. FHIT mRNA and protein expression in hepatocellular carcinoma. Mod Pathol. 2004 Jun; 17(6):653-9.
    View PubMed
  195. Oben JA, Roskams T, Yang S, Lin H, Sinelli N, Torbenson M, Smedh U, Moran TH, Li Z, Huang J, Thomas SA, Diehl AM. Hepatic fibrogenesis requires sympathetic neurotransmitters. Gut. 2004 Mar; 53(3):438-45.
    View PubMed
  196. Lee J, Li S, Torbenson M, Liu QZ, Lind S, Mulvihill JJ, Bane B, Wang J. Leiomyosarcoma of the breast: a pathologic and comparative genomic hybridization study of two cases. Cancer Genet Cytogenet. 2004 Feb; 149(1):53-7.
    View PubMed
  197. Torbenson M, Kannangai R, Astemborski J, Strathdee SA, Vlahov D, Thomas DL. High prevalence of occult hepatitis B in Baltimore injection drug users. Hepatology. 2004 Jan; 39(1):51-7.
    View PubMed
  198. Koteish A, Kannangai R, Abraham SC, Torbenson M. Colonic spirochetosis in children and adults. Am J Clin Pathol. 2003 Dec; 120(6):828-32.
    View PubMed
  199. Torbenson M, Wang JZ, Abraham S, Maitra A, Boitnott J. Bile ducts and ductules are positive for CD56 (N-CAM) in most cases of extrahepatic biliary atresia. Am J Surg Pathol. 2003 Nov; 27(11):1454-7.
    View PubMed
  200. Hoofring A, Boitnott J, Torbenson M. Three-dimensional reconstruction of hepatic bridging fibrosis in chronic hepatitis C viral infection. J Hepatol. 2003 Nov; 39(5):738-41.
    View PubMed
  201. Hawxby AM, Torbenson M, Fishman E, Lawler L, Arrazola LM, Klein AS. Juxta-caval hepatic angiomyolipoma masquerading as hepatocellular carcinoma. Hepatobiliary Pancreat Dis Int. 2003 Nov; 2(4):617-21.
    View PubMed
  202. Ulanet DB, Torbenson M, Dang CV, Casciola-Rosen L, Rosen A. Unique conformation of cancer autoantigen B23 in hepatoma: a mechanism for specificity in the autoimmune response. Proc Natl Acad Sci U S A. 2003 Oct 14; 100(21):12361-6. Epub 2003 Sep 30.
    View PubMed
  203. Kamel IR, Bluemke DA, Ramsey D, Abusedera M, Torbenson M, Eng J, Szarf G, Geschwind JF. Role of diffusion-weighted imaging in estimating tumor necrosis after chemoembolization of hepatocellular carcinoma. AJR Am J Roentgenol. 2003 Sep; 181(3):708-10.
    View PubMed
  204. Oben JA, Roskams T, Yang S, Lin H, Sinelli N, Li Z, Torbenson M, Huang J, Guarino P, Kafrouni M, Diehl AM. Sympathetic nervous system inhibition increases hepatic progenitors and reduces liver injury. Hepatology. 2003 Sep; 38(3):664-73.
    View PubMed
  205. Wang J, Blakey GL, Zhang L, Bane B, Torbenson M, Li S. Uterine tumor resembling ovarian sex cord tumor: report of a case with t(X;6)(p22.3;q23.1) and t(4;18)(q21.1;q21.3). Diagn Mol Pathol. 2003 Sep; 12(3):174-80.
    View PubMed
  206. Oben JA, Roskams T, Yang S, Lin H, Sinelli N, Li Z, Torbenson M, Thomas SA, Diehl AM. Norepinephrine induces hepatic fibrogenesis in leptin deficient ob/ob mice. Biochem Biophys Res Commun. 2003 Aug 22; 308(2):284-92.
    View PubMed
  207. Dang DT, Chen X, Feng J, Torbenson M, Dang LH, Yang VW. Overexpression of Kruppel-like factor 4 in the human colon cancer cell line RKO leads to reduced tumorigenecity. Oncogene. 2003 May 29; 22(22):3424-30.
    View PubMed
  208. Wang J, Torbenson M, Wang Q, Ro JY, Becich M. Expression of inducible nitric oxide synthase in paired neoplastic and non-neoplastic primary prostate cell cultures and prostatectomy specimen. Urol Oncol. 2003 Mar-Apr; 21(2):117-22.
    View PubMed
  209. Akpek G, Chinratanalab W, Lee LA, Torbenson M, Hallick JP, Anders V, Vogelsang GB. Gastrointestinal involvement in chronic graft-versus-host disease: a clinicopathologic study. Biol Blood Marrow Transplant. 2003 Jan; 9(1):46-51.
    View PubMed
  210. Torbenson M, Erlen J. A case study of the Lash's Bitters company - Advertising changes after the Federal Food and Drugs Act of 1906 and the Sherley Amendment of 1912. Pharm Hist. 2003; 45(4):139-49.
    View PubMed
  211. Akpek G, Boitnott JK, Lee LA, Hallick JP, Torbenson M, Jacobsohn DA, Arai S, Anders V, Vogelsang GB. Hepatitic variant of graft-versus-host disease after donor lymphocyte infusion. Blood. 2002 Dec 1; 100(12):3903-7. Epub 2002 Jul 18.
    View PubMed
  212. Gebo KA, Herlong HF, Torbenson MS, Jenckes MW, Chander G, Ghanem KG, El-Kamary SS, Sulkowski M, Bass EB. Role of liver biopsy in management of chronic hepatitis C: a systematic review. Hepatology. 2002 Nov; 36(5 Suppl 1):S161-72.
    View PubMed
  213. Chander G, Sulkowski MS, Jenckes MW, Torbenson MS, Herlong HF, Bass EB, Gebo KA. Treatment of chronic hepatitis C: a systematic review. Hepatology. 2002 Nov; 36(5 Suppl 1):S135-44.
    View PubMed
  214. Gebo KA, Chander G, Jenckes MW, Ghanem KG, Herlong HF, Torbenson MS, El-Kamary SS, Bass EB. Screening tests for hepatocellular carcinoma in patients with chronic hepatitis C: a systematic review. Hepatology. 2002 Nov; 36(5 Suppl 1):S84-92.
    View PubMed
  215. Montgomery E, Torbenson MS, Kaushal M, Fisher C, Abraham SC. Beta-catenin immunohistochemistry separates mesenteric fibromatosis from gastrointestinal stromal tumor and sclerosing mesenteritis. Am J Surg Pathol. 2002 Oct; 26(10):1296-301.
    View PubMed
  216. Cruz-Correa M, Milligan F, Giardiello FM, Bayless TM, Torbenson M, Yardley JH, Jackson FW, Wilson Jackson F. Collagenous colitis with mucosal tears on endoscopic insufflation: a unique presentation. Gut. 2002 Oct; 51(4):600.
    View PubMed
  217. Torbenson M, Marinopoulos S, Dang DT, Choti M, Ashfaq R, Maitra A, Boitnott J, Wilentz RE. Smad4 overexpression in hepatocellular carcinoma is strongly associated with transforming growth factor beta II receptor immunolabeling. Hum Pathol. 2002 Sep; 33(9):871-6.
    View PubMed
  218. Torbenson M, Wang J, Choti M, Ashfaq R, Maitra A, Wilentz RE, Boitnott J. Hepatocellular carcinomas show abnormal expression of fibronectin protein. Mod Pathol. 2002 Aug; 15(8):826-30.
    View PubMed
  219. Torbenson M, Thomas DL. Occult hepatitis B. Lancet Infect Dis. 2002 Aug; 2(8):479-86.
    View PubMed
  220. Geschwind JF, Ko YH, Torbenson MS, Magee C, Pedersen PL. Novel therapy for liver cancer: direct intraarterial injection of a potent inhibitor of ATP production. Cancer Res. 2002 Jul 15; 62(14):3909-13.
    View PubMed
  221. Torbenson M, Lee JH, Cruz-Correa M, Ravich W, Rastgar K, Abraham SC, Wu TT. Sporadic fundic gland polyposis: a clinical, histological, and molecular analysis. Mod Pathol. 2002 Jul; 15(7):718-23.
    View PubMed
  222. Torbenson M, Yang SQ, Liu HZ, Huang J, Gage W, Diehl AM. STAT-3 overexpression and p21 up-regulation accompany impaired regeneration of fatty livers. Am J Pathol. 2002 Jul; 161(1):155-61.
    View PubMed
  223. Gebo KA, Jenckes MW, Chander G, Torbenson MS, Ghanem KG, Herlong HF, Sulkowski MS, El-Kamary SS, Harris KA, Guedelhoefer OC, Bass EB. Management of chronic hepatitis C. Evid Rep Technol Assess (Summ). 2002 Jun(60):1-7.
    View PubMed
  224. Torbenson M, Montgomery EA, Iacobuzio-Donahue C, Yardley JH, Wu TT, Abraham SC. Colchicine effect in a colonic hyperplastic polyp. A lesion mimicking serrated adenoma. Arch Pathol Lab Med. 2002 May; 126(5):615-7.
    View PubMed
  225. Rai R, Wilson LE, Astemborski J, Anania F, Torbenson M, Spoler C, Vlahov D, Strathdee SA, Boitnott J, Nelson KE, Thomas DL. Severity and correlates of liver disease in hepatitis C virus-infected injection drug users. Hepatology. 2002 May; 35(5):1247-55.
    View PubMed
  226. Torbenson M, Lee JH, Choti M, Gage W, Abraham SC, Montgomery E, Boitnott J, Wu TT. Hepatic adenomas: analysis of sex steroid receptor status and the Wnt signaling pathway. Mod Pathol. 2002 Mar; 15(3):189-96.
    View PubMed
  227. Torbenson M, Abraham SC, Boitnott J, Yardley JH, Wu TT. Autoimmune gastritis: distinct histological and immunohistochemical findings before complete loss of oxyntic glands. Mod Pathol. 2002 Feb; 15(2):102-9.
    View PubMed
  228. Torbenson M, Randhawa P. Arcuate and interlobular phlebitis in renal allografts. Hum Pathol. 2001 Dec; 32(12):1388-91.
    View PubMed
  229. Bellamy CO, DiMartini AM, Ruppert K, Jain A, Dodson F, Torbenson M, Starzl TE, Fung JJ, Demetris AJ. Liver transplantation for alcoholic cirrhosis: long term follow-up and impact of disease recurrence. Transplantation. 2001 Aug 27; 72(4):619-26.
    View PubMed
  230. Torbenson MS, Wang J, Nichols L, Jain AB, Fung JJ, Nalesnik MA. Occult nonhematopoietic malignancies present at autopsy in solid organ transplant patients who died within 100 days. Transplantation. 2001 Jan 15; 71(1):64-9.
    View PubMed
  231. Torbenson B, Erlen J, Torbenson M. Pharmacy in History. Pharmacy in History. 2001; 43:14-22.
  232. Wang J, Krill D, Torbenson M, Wang Q, Bisceglia M, Stoner J, Thomas A, DeFlavia P, Dhir R, Becich MJ. Expression of cadherins and catenins in paired tumor and non-neoplastic primary prostate cultures and corresponding prostatectomy specimens. Urol Res. 2000 Oct; 28(5):308-15.
    View PubMed
  233. Minervini MI, Torbenson M, Scantlebury V, Vivas C, Jordan M, Shapiro R, Randhawa PS. Acute renal allograft rejection with severe tubulitis (Banff 1997 grade IB). Am J Surg Pathol. 2000 Apr; 24(4):553-8.
    View PubMed
  234. Torbenson M, Wang J, Nichols L, Randhawa P, Nalesnik MA. Renal cortical neoplasms in long term survivors of solid organ transplantation. Transplantation. 2000 Mar 15; 69(5):864-8.
    View PubMed
  235. Torbenson M. Lash's - a bitter medicine: biochemical analysis of an historical proprietary medicine. Hist Archaeol. 2000; 34(2):56-64.
    View PubMed
  236. Torbenson M, Dhir R, Nangia A, Becich MJ, Kapadia SB. Prostatic carcinoma with signet ring cells: a clinicopathologic and immunohistochemical analysis of 12 cases, with review of the literature. Mod Pathol. 1998 Jun; 11(6):552-9.
    View PubMed
  237. Torbenson M, Wang J, Nichols L, Jain A, Fung J, Nalesnik MA. Causes of death in autopsied liver transplantation patients. Mod Pathol. 1998 Jan; 11(1):37-46.
    View PubMed
  238. Torbenson M, Langsjoen O, Aufderheide A. Human remains from Mckinstry mound two. Plains Anthropologist. 1996; 41(155):71-92.
  239. Torbenson M, Langsjoen O, Aufderheide A. Laurel culture human remains from Smith mounds three and four. Plains Anthrologist. 1994; 39(150):429-44.
  240. Torbenson M, Aufderheide A, Johnson E. Punctured human long bones from Smith mound four, Minnesota. American Antiquity. 1992; 57(3):506-14.
PST-20305314